Duncan M E, Reimann K, Tibaux G, Pelzer A, Mehari L, Lind I
Department of Bacteriology, University of Edinburgh, Scotland.
Genitourin Med. 1991 Dec;67(6):485-92. doi: 10.1136/sti.67.6.485.
To measure the prevalence of gonorrhoea in Ethiopian women attending gynaecologic, obstetric and family planning clinics: to determine the reliability of patient self history of sexually transmitted disease (STD); to correlate the serological diagnosis of gonorrhoea with clinical evidence of pelvic infection in order to define a reliable clinical diagnosis of gonorrhoea in a country where pelvic inflammatory disease is very common but where routine laboratory culture and serological tests for gonorrhoea are unavailable.
1851 Ethiopian women: 50% symptomatic, 50% asymptomatic.
Gynaecological outpatient department, antenatal, postnatal and family planning clinics (Ethiopian Family Guidance Association (EFGA)), in two teaching hospitals and a mother and child health centre in Addis Ababa, Ethiopia.
The indirect haemagglutination test with gonococcal pilus antigen as an epidemiological tool was used in a cross-section study to screen 1851 sera for evidence of past or current gonococcal infection. The gonococcal antibody test (GAT) seropositivity was correlated with patient's history of STD, age, clinic attended and the clinical evidence of infection in "gonococcal target organs" urethra, salpinges or Bartholin glands.
Fifty nine per cent of the study group were seropositive for the gonococcal antibody test, 22% with titres greater than or equal to 1/320, indicative of current, recent or recurrent infection. Seropositivity indicating past or present gonococcal infection was highest in those who gave a history of having had treated syphilis (85%), in women aged 40-49 (72%), and family planning attenders (EFGA) (66%) of whom 31% had titres greater than or equal to 1/320. Fifty per cent had clinical evidence of past or present infection in the urethra, salpinges or Bartholin glands. Gonococcal antibodies were present in 54% of women with no evidence of clinical infection, compared with 91% of those with pyosalpinx and 86% of those with triple infection of urethra, salpinges and Bartholin glands.
The high prevalence of gonococcal antibodies in Ethiopian women, especially in asymptomatic clinic attenders must be of concern for all health workers especially those in gynaecology and obstetrics and the related disciplines of family planning and neonatal paediatrics. While seropositivity was highest in those giving a past history of syphilis, the patient's history of STD was unreliable, as of those who denied having any history of STD, fifty per cent were GAT seropositive. Despite a high correlation between GAT seropositivity with pyosalpinx and clinical evidence of infection in urethra, salpinges and bartholin glands, gonococcal antibodies were present in 54% of women with no clinical evidence of infection. Thus we were unable to define a diagnostic clinical picture of gonorrhoea in Ethiopian women.
测定在埃塞俄比亚妇科、产科和计划生育诊所就诊的女性中淋病的患病率;确定患者性传播疾病(STD)自我病史的可靠性;将淋病的血清学诊断与盆腔感染的临床证据相关联,以便在盆腔炎非常常见但无法进行淋病常规实验室培养和血清学检测的国家确定可靠的淋病临床诊断。
1851名埃塞俄比亚女性,其中50%有症状,50%无症状。
埃塞俄比亚亚的斯亚贝巴的两家教学医院和一家母婴健康中心的妇科门诊部、产前、产后和计划生育诊所(埃塞俄比亚家庭指导协会(EFGA))。
在一项横断面研究中,使用以淋球菌菌毛抗原为流行病学工具的间接血凝试验,对1851份血清进行筛查,以寻找既往或当前淋球菌感染的证据。将淋球菌抗体试验(GAT)血清阳性与患者的性传播疾病病史、年龄、就诊诊所以及“淋球菌靶器官”尿道、输卵管或巴氏腺的感染临床证据相关联。
研究组中59%的人淋球菌抗体试验呈血清阳性,22%的人滴度大于或等于1/320,表明当前、近期或反复感染。有梅毒治疗史的人(85%)、40 - 49岁的女性(72%)以及计划生育门诊患者(EFGA)(66%)中,表明既往或当前淋球菌感染的血清阳性率最高,其中31%的人滴度大于或等于1/320。50%的人有尿道、输卵管或巴氏腺既往或当前感染的临床证据。54%无临床感染证据的女性存在淋球菌抗体,相比之下,输卵管积脓患者中有91%存在淋球菌抗体,尿道、输卵管和巴氏腺三重感染患者中有86%存在淋球菌抗体。
埃塞俄比亚女性中淋球菌抗体的高患病率,尤其是无症状门诊患者中的高患病率,必须引起所有医护人员的关注,尤其是妇产科以及计划生育和新生儿儿科等相关学科的医护人员。虽然有梅毒既往史的人血清阳性率最高,但患者的性传播疾病病史不可靠,因为那些否认有任何性传播疾病病史的人中,50%的人GAT血清呈阳性。尽管GAT血清阳性与输卵管积脓以及尿道、输卵管和巴氏腺感染的临床证据之间存在高度相关性,但54%无临床感染证据的女性存在淋球菌抗体。因此,我们无法确定埃塞俄比亚女性淋病的诊断临床表现。